Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

Veolia Deepens US Waste And Water Role With Long Term Contract Focus

Veolia Environnement announced a new US hazardous waste acquisition, expanding its presence in the North American market. The company is extending its PFAS treatment capabilities across North America to address growing water quality challenges. Veolia and the National Association of Water Companies published a policy white paper calling for large scale water infrastructure investment in the US. Veolia Environnement (ENXTPA:VIE), trading at €32.4, has seen its share price return 7.5% year to...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Voyager Technologies (VOYG) Is Down 5.2% After 2025 Losses Widen, Max Space Investment Announced - Has The Bull Case Changed?

Voyager Technologies recently reported its fourth-quarter and full-year 2025 results, showing sales rising to US$46.65 million for the quarter and US$166.42 million for the year, while losses widened, alongside issuing 2026 sales guidance of US$225 million to US$255 million and announcing a multi-million-dollar investment in Max Space to advance expandable space habitats supporting NASA’s Artemis Program. This combination of increased sales, deeper investment in space infrastructure, and a...
NYSE:NVRI
NYSE:NVRICommercial Services

Should Widening Losses Amid Stable Sales Require Action From Enviri (NVRI) Investors?

Enviri Corporation recently reported its fourth-quarter and full-year 2025 results, with full-year revenue of US$2,240.36 million versus US$2,343.14 million a year earlier and a wider net loss of US$167.60 million compared with US$129.65 million. The persistence of losses and higher loss per share, despite relatively steady revenue, highlights pressure on profitability and the company’s ongoing financial strain. With these earnings showing revenue slippage and a larger annual loss, we’ll now...
XTRA:GYC
XTRA:GYCReal Estate

Aroundtown Offer Puts Grand City Properties Valuation And Control In Focus

Aroundtown has launched a voluntary public exchange offer to acquire an additional stake in Grand City Properties. The Board of Grand City Properties has publicly supported the offer. The move introduces fresh M&A considerations for shareholders in XTRA:GYC. For you as a shareholder, the Aroundtown exchange offer puts Grand City Properties (XTRA:GYC) in the middle of a potential change in control discussion at a time when the stock trades around €9.87. Over 3 years, the share price return...
NYSE:OI
NYSE:OIPackaging

Why O-I Glass (OI) Is Down 13.6% After Tougher Q1 2026 Europe And Pricing Pressure

O-I Glass recently reported that the first quarter of 2026 was tougher than expected, citing softer European demand, supply chain costs from factory closures, and pricing pressure in wine, even as it kept its full-year outlook unchanged. At the same time, the company nearly doubled adjusted earnings to US$1.60 per share in 2025, lifted by US$300 million of Fit to Win savings, and raised its three-year efficiency target to at least US$750 million, underscoring management’s focus on...
TSX:DCBO
TSX:DCBOSoftware

Docebo Buyback And 365Talents Deal Test Market Pessimism

Docebo (TSX:DCBO) has agreed to acquire 365Talents to expand its AI driven skills intelligence capabilities for learning and talent development. The company also launched a CA$60 million substantial issuer bid to repurchase its own shares. For investors watching TSX:DCBO, these moves arrive after a challenging multi year share price stretch. The stock closed at CA$25.74, with returns of 6.5% over the past week but declines of 1.3% over 30 days, 16.4% year to date, 39.8% over 1 year, 49.6%...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss

AbCellera Biologics (ABCL) is back in focus after releasing full year 2025 results, reporting revenue of US$75.13 million compared with US$28.83 million a year earlier and a net loss of US$146.41 million compared with US$162.86 million. See our latest analysis for AbCellera Biologics. AbCellera Biologics’ latest earnings drop comes after a mixed period for investors, with a 1-month share price return of 11.39% but a 3-year total shareholder return decline of 52.56% and a 5-year total...
NYSE:CR
NYSE:CRMachinery

Crane (CR) Valuation Check After Q4 2025 Earnings Reignite Growth And Lift Analyst Expectations

Q4 2025 earnings shift focus back to Crane’s top line Crane (CR) is back in the spotlight after reporting higher sales and earnings for Q4 and full year 2025, ending a multi year revenue decline and prompting analysts to revisit their growth assumptions. See our latest analysis for Crane. Crane’s recent Q4 update lands after a strong run for long term holders, with a 1 year total shareholder return of 26.62% and a 5 year total shareholder return of 231.46%. At the same time, the 7 day share...
XTRA:BEI
XTRA:BEIPersonal Products

Assessing Beiersdorf (XTRA:BEI) Valuation After Its Shift To 100% Recycled Aluminium Aerosol Cans

Beiersdorf (XTRA:BEI) is drawing fresh attention after converting all its European aerosol cans to 100% post consumer recycled aluminium in partnership with Ball Corporation. The move is tied directly to its long term net zero plans. See our latest analysis for Beiersdorf. Those sustainability headlines arrive during a weak patch for the shares, with a 7 day share price return of 22.69% and a 30 day share price return of 21.61%. This has contributed to a 1 year total shareholder return of...
NasdaqCM:LTRX
NasdaqCM:LTRXCommunications

MediaTek Edge AI Expansion and EU Deal Could Be A Game Changer For Lantronix (LTRX)

In early March 2026, Lantronix Inc. expanded its embedded compute platform with new MediaTek Genio-based System-on-Module solutions and signed a European distribution partnership with Milan-based Melchioni Electronics to broaden sales and technical support across key EU markets. Together, the MediaTek-powered Edge AI modules and Melchioni’s regional reach materially widen Lantronix’s addressable markets, design-win potential and supply resilience across industrial and commercial IoT...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Can Willdan Group's (WLDN) New PSE Software Wins Redefine Its Energy Infrastructure Strategy?

In early March 2026, Willdan Group, Inc. announced it had been chosen by Puget Sound Energy to implement telecommunications and multifamily new construction programs, expand non-lighting technologies for a commercial program, and deliver software services supporting compliance with Washington State’s Clean Buildings Performance Standard. These wins, alongside a US$49 million distributed energy resources contract with Mt. San Antonio College and strong 2025 financial results, highlight...
SEHK:2319
SEHK:2319Food

Does China Mengniu (SEHK:2319) Impairment Shift Reveal a New Balance Between Efficiency and Shareholder Cash?

China Mengniu Dairy Company Limited was recently removed from the Hang Seng China Enterprises Index and announced plans to book RMB 2.20–2.40 billion in impairment provisions on idle production facilities and certain financial and contract assets. At the same time, the company has scheduled a March 25, 2026 board meeting to approve its 2025 annual results and consider a final dividend, underscoring a balance between addressing asset quality issues and potential cash returns to...
ENXTAM:ASM
ENXTAM:ASMSemiconductor

How Investors May Respond To ASM International (ENXTAM:ASM) Dividend Hike And €150 Million Buyback Plan

ASM International N.V. has reported its 2025 results, issued revenue guidance for 2026, proposed lifting its regular dividend to €3.25 per share, and authorized up to €150 million of share repurchases funded from excess cash. While fourth-quarter sales and earnings eased from the prior year, the combination of higher full-year profit, raised dividend, and new buyback plan signals confidence in the company’s cash generation and balance sheet strength. Next, we’ll examine how ASM...
NYSE:AZZ
NYSE:AZZBuilding

Is AZZ (AZZ) Quietly Recasting Its Board to Sharpen Capital Allocation Discipline?

AZZ Inc. recently reshaped its governance, appointing Myers Industries CEO Aaron Schapper and Vistance Networks CEO Charles “Chuck” Treadway to its Board effective April 8, 2026, while long-time chair Dan Feehan stepped down in March and was succeeded by director Dan Berce, with Feehan remaining on the Board until July 2026. These board changes, alongside an expanded stock repurchase authorization and ongoing leadership refresh, highlight AZZ’s focus on strengthening oversight, capital...
TSX:MTL
TSX:MTLTransportation

Mullen Group (TSX:MTL) Valuation Check As Renewed Share Buyback Signals Management Confidence

Why Mullen Group’s renewed buyback matters now Mullen Group (TSX:MTL) recently secured Toronto Stock Exchange approval to renew its normal course issuer bid, allowing repurchases of up to 8,929,176 common shares between March 11, 2026 and March 10, 2027. This sizable authorization, together with a regular CA$0.07 cash dividend with an ex dividend date of February 27, 2026, places capital returns to shareholders at the center of the current Mullen Group discussion. See our latest analysis for...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Assessing Septerna (SEPN) Valuation After Earnings Progress And Positive SEP-631 Phase 1 Results

Earnings and clinical progress set the stage for Septerna (SEPN) Septerna (SEPN) has drawn fresh attention after reporting fourth quarter and full year 2025 results alongside positive Phase 1 data for SEP-631 in chronic urticaria, a combination that puts both finances and pipeline in focus. See our latest analysis for Septerna. The recent earnings update and SEP-631 Phase 1 readout come after a strong run, with a 1 year total shareholder return of around 4x and a 30 day share price return of...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO Highlights Women In Roofing As It Builds Contractor Relationships

QXO (NYSE:QXO) has launched its sixth annual North American Female Roofing Professional of the Year campaign. The initiative recognizes women across the roofing industry and reflects QXO’s focus on workforce inclusivity. The campaign invites nominations of standout female professionals, offering company backed recognition and support. For you as an investor, this campaign speaks to how QXO is positioning itself within the roofing supply and services ecosystem, not just as a distributor or...
OM:TELIA
OM:TELIATelecom

Assessing Telia Company (OM:TELIA) Valuation As Lithuania AI Data Center Project Gains Attention

Why Telia Company (OM:TELIA) is Back on Investors’ Radar Telia Company (OM:TELIA) is in focus after its Lithuanian unit, Telia Lietuva, started building a €26 million, renewables powered data center near Vilnius. The project targets growing AI related demand and aims to provide higher reliability across its regional network. See our latest analysis for Telia Company. That data center announcement lands at a time when Telia Company’s share price has gained 21.49% over the past 90 days and...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

Assessing Enterprise Financial Services (EFSC) Valuation After Recent Short Term Share Price Weakness

Event context and recent share performance Enterprise Financial Services (EFSC) has drawn investor attention after recent trading, with the stock down about 1% over the past day, 6% over the past week, and roughly 10% over the past month. Those shorter term moves contrast with a small positive total return over the past year, as well as higher three and five year total returns. This has prompted some investors to reassess how the bank’s current pricing lines up with its fundamentals. See our...
TSE:2503
TSE:2503Beverage

Does Kirin’s Personalized Gut Microbiome Push Reshape Its Health-Nutrition Strategy (TSE:2503)?

Cowellnex, Kyowa Kirin and Metagen have begun joint research to develop gut microbiota tests and personalized food recommendation algorithms for Japanese individuals, using Cowellnex’s high-precision shotgun metagenomic data accumulated over roughly three years. The collaboration highlights how advanced microbiome analytics could underpin new personalized gut health services, potentially expanding Kirin’s reach in science-based health and nutrition solutions. Next, we’ll examine how this...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

A Look At Energy Recovery (ERII) Valuation After PX Q650 Desalination Launch

Why the PX Q650 launch matters for Energy Recovery (ERII) investors Energy Recovery (ERII) has drawn fresh attention after launching its PX Q650 Pressure Exchanger for desalination, combining higher flow capacity, very high stated efficiency, and extended warranties aimed at long-life plant operations. See our latest analysis for Energy Recovery. The PX Q650 launch comes on the heels of Energy Recovery’s recent earnings update. It arrives at a time when the stock has seen a 4.81% 1 day share...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Is New HIV Switch Data Reframing the Investment Case for Gilead Sciences’ Lenacapavir Platform (GILD)?

In February 2026, Gilead Sciences presented Phase 3 ARTISTRY-1 and ARTISTRY-2 data showing its investigational single-tablet bictegravir/lenacapavir HIV regimen maintained virologic suppression and was generally well tolerated, proving noninferior to both complex multi-tablet regimens and guideline-recommended single-tablet therapy through Week 48. This potential new once-daily option could simplify treatment for people living with HIV who are currently on complex regimens, reinforcing...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

Does IES Holdings (IESC) Director Share Sale Recast the Story on Governance and Capital Allocation?

IES Holdings recently held its 2026 Annual Stockholders Meeting, where all director nominees were elected and Ernst & Young was ratified as auditor, while Director Todd Cleveland sold 2,500 shares, trimming his personal stake. Together with ongoing attention on the Gulf Island acquisition, these governance developments are sharpening investor focus on how IES allocates capital and manages oversight. Next, we’ll examine how the director’s share sale and refreshed governance framework shape...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Profit Swing, MIPLYFFA Uptake and New CFO Might Change The Case For Investing In Zevra Therapeutics (ZVRA)

Zevra Therapeutics, Inc. has reported its 2025 results, with full-year sales rising to US$106.47 million and net income reaching US$83.23 million, alongside fourth-quarter revenue of US$34.1 million and adjusted earnings of US$1.16 per share. Alongside these results, Zevra filed a US$22.86 million employee stock offering and named veteran finance executive Justin Renz as its new Chief Financial Officer, underscoring a focus on commercial scale-up and corporate development. We’ll now examine...